United States

 

Cigna and Humana deal off

Contrary to speculation that a deal would be announced by Christmas, two of the largest health insurers in the US - Cigna and Humana - will not be merging to form a $140bn giant insurer. After reportedly failing to agree on a price, Cigna is instead reportedly planning to buy back $10bn worth of shares.
December 15, 2023

Cigna and Humana “in talks to merge”

Two of the US’s largest health insurers - Cigna and Humana - are reportedly in talks to merge. A stock-and-cash megadeal could be announced by the end of the year, but any deal will likely attract the interest of the regulator.
December 1, 2023

Fresenius Medical Care deconsolidation completed

The deconsolidation of multinational dialysis giant Fresenius Medical Care (FMC) from German health care conglomerate Fresenius Group has been completed. This means FMC is now a regular limited liability stock corporation; Fresenius Group still holds the largest minority stake (of 32.2%) in it but no longer has control over, nor unlimited liability in it.
November 30, 2023

PureHealth set to IPO

UAE-based healthcare provider PureHealth looks set to IPO in the coming months, with multiple sources suggesting it will list on the Abu Dhabi Securities Exchange.
November 24, 2023

Eugin sells for €500m

Healthcare conglomerate Fresenius has sold Eugin, its Spain-based fertility business, to KKR-owned fertility group IVI RMA and Spain-based asset management firm GED for €500m including earn-outs.
November 10, 2023

Blackstone buys CARE Hospitals and KIMS Health

Global private equity firm Blackstone has entered the Indian hospital market with two big acquisitions. It is acquiring a 75% stake in Hyderbad-based CARE Hospitals. In a separate deal, CARE is buying a majority stake in rival group KIMS Health. The plan is to merge the two groups and create one of India's largest hospital chains. 
November 3, 2023

Interview: Jim Kean, CEO, Molecular You

HBI speaks to Jim Kean, CEO of Molecular You, a North American start-up that does tests which analyse patients' proteins and metabolites (small molecules produced during metabolism) to predict what diseases they are at risk of having. Kean tells us that through the use of hundreds of biomarkers and with the help of AI, they are able to achieve a 98% predictive accuracy for certain conditions.
September 22, 2023

Interview: Walter Shekman, CEO, Dobrobut

Against the backdrop of the Russia-Ukraine war, HBI speaks to the CEO of the Ukrainian hospital group Dobrobut, Walter Shekman, to understand the day-to-day challenges it is facing, and how the private sector can assist the sector.
September 15, 2023

Babylon saga reaches end

Digital unicorn-turned-mouse Babylon Health has placed two of its UK divisions into administration and reportedly sold its clinical services business to US digital health firm eMed Healthcare.
September 1, 2023

Buy or bust for Babylon UK?

Digital health unicorn-turned-mouse Babylon could still have buyers for its UK business, despite its recent difficulties.
August 18, 2023
Newer posts
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us